Healthway Internal Medicine & Pediatrics PLLC
Healthway Internal Medicine & Pediatrics PLLC was paid $2.63M by Medicaid between Jan 2018 and Nov 2024, across 83 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.
ELIZABETHTOWN, KY 42701
Next to other Pediatrics Physician providers in Kentucky
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,547 | $470K | |
| 2019 | 14,517 | $430K | |
| 2020 | 10,366 | $296K | |
| 2021 | 14,692 | $368K | |
| 2022 | 14,178 | $413K | |
| 2023 | 13,921 | $355K | |
| 2024incomplete | 16,821 | $302K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35% | 19,267 | 17,969 | $931K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 19,337 | 17,766 | $667K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 6.2% | 1,950 | 1,882 | $164K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 5.3% | 3,263 | 3,129 | $140K |
| 99173 | 3.9% | 2,956 | 2,907 | $103K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.3% | 3,230 | 3,087 | $88K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.1% | 2,931 | 1,918 | $56K |
| 99490 | Ccm add 20min | 1.5% | 3,214 | 2,888 | $39K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 2,551 | 2,451 | $36K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.3% | 586 | 581 | $35K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.2% | 445 | 439 | $32K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.2% | 420 | 399 | $32K |
71 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.2% | 300 | $32K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.0% | 314 | $27K |
| 80306 | 1.0% | 1,744 | $27K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,258 | $20K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 249 | $17K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 561 | $17K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 245 | $16K |
| 99442 | <1% | 341 | $16K | |
| 87430 | <1% | 1,019 | $16K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 981 | $15K |
| 90461 | <1% | 521 | $14K | |
| 99205 | Prolong outpt/office vis | <1% | 92 | $11K |
| 90688 | <1% | 767 | $9K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 235 | $8K |
| 90686 | <1% | 496 | $7K | |
| 90674 | <1% | 300 | $7K | |
| 80305 | <1% | 565 | $6K | |
| 90633 | <1% | 340 | $4K | |
| D1206 | Topical application of fluoride varnish | <1% | 288 | $4K |
| 90656 | <1% | 612 | $4K | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 2,646 | $3K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 2,638 | $3K |
| 80061 | Lipid panel | <1% | 225 | $3K |
| 99407 | <1% | 78 | $3K | |
| 99406 | <1% | 321 | $3K | |
| 90677 | <1% | 13 | $2K | |
| 81003 | <1% | 1,957 | $2K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 37 | $2K |
| 90621 | <1% | 116 | $2K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,005 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 26 | $2K |
| 84703 | <1% | 196 | $1K | |
| 87807 | <1% | 94 | $1K | |
| 99383 | <1% | 13 | $854.06 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 98 | $832.08 |
| 99188 | <1% | 56 | $778.87 | |
| 90649 | <1% | 61 | $736.00 | |
| 90734 | <1% | 42 | $653.20 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 12 | $622.75 |
| 87634 | <1% | 15 | $518.39 | |
| 90651 | <1% | 43 | $382.40 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 13 | $48.77 |
| 3008F | <1% | 7,226 | $39.73 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 382 | $32.50 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 334 | $32.50 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 18 | $25.00 |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | <1% | 16 | $2.50 |
| 1126F | <1% | 686 | $0.99 | |
| 3074F | <1% | 720 | $0.94 | |
| 1170F | <1% | 412 | $0.69 | |
| 3078F | <1% | 532 | $0.59 | |
| 90756 | <1% | 16 | $0.46 | |
| 3079F | <1% | 187 | $0.24 | |
| 3075F | <1% | 48 | $0.06 | |
| 1159F | <1% | 530 | $0.06 | |
| 1160F | <1% | 566 | $0.06 | |
| 3080F | <1% | 17 | $0.04 | |
| 3077F | <1% | 21 | $0.04 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 457 | $0.02 |
| 1125F | <1% | 16 | $0.01 | |
| G0008 | Administration of influenza virus vaccine | 0% | 61 | $0.00 |
| 1036F | 0% | 347 | $0.00 | |
| 1101F | 0% | 84 | $0.00 | |
| 90620 | 0% | 13 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 1,985 | $0.00 |
| 3288F | 0% | 85 | $0.00 | |
| 2014F | 0% | 1,141 | $0.00 | |
| 4004F | 0% | 16 | $0.00 | |
| 99051 | 0% | 17 | $0.00 | |
| 90670 | 0% | 14 | $0.00 | |
| 90648 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Elite Endoscopy LLC | Las Vegas, NV | $1000K |
| Nephrology Associates of the Carolinas, P.A. | Shelby, NC | $785K |
| Antelope Valley Lung & Sleep Institute, INC | Palmdale, CA | $725K |
| Cleveland Psychiatry Associates LLC | Brecksville, OH | $517K |
| S H Ahmed MD PHD INC | El Centro, CA | $483K |
| Av Intensivist Group INC | Palmdale, CA | $93K |
| Zeedoc,llc | Las Vegas, NV | $65K |
| Capital Internal Medicine & Geriatrics, P.A. | Raleigh, NC | $61K |
| Psychiatric Care INC | Fredericksburg, VA | $54K |
| Western Labs Company | Chicago, IL | $8K |
| Advance Lab Company | Chicago, IL | $1K |
| Vital Signs Physicians FL PL | Kissimmee, FL | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.